Ackman Sees Confidence Restored in Valeant Pharma (VRX) After 10-K Filed, New Leadership Identified
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/9/2026
- Wall Street posts weekly gains with earnings, inflation data on tap
- Oil prices settle higher as more production shut ahead of hurricane
- Apple cuts iPhone 18 Pro orders due to soft demand, Nikkei Asia reports
- UBS flags level in gold prices where dip buyers will likely emerge
- Telecom stocks tumble on SpaceX spectrum acquisition news
- US consumer sentiment near record low as frustration over economy mounts
- 8.0 Mag. Earthquake 14 Km Sw Of Pitaloza Arriba Panama - USGS
- Strong Panama quake shakes nation, but avoids major destruction
- SpaceX to acquire Grain Management's 800 MHz spectrum portfolio
- CoreWeave stock drops on dilution fears and debt concerns
Pershing Square cooperating with U.S. probe - Reuters
March 24, 2016 4:18 PM EDTPershing Square cooperating with U.S. probe - Reuters
... MoreValeant Pharma (VRX) Enters Information Sharing Agreement with Pershing Square
March 23, 2016 4:37 PM EDTPershing Square filed an amended 13D on Valeant Pharma (NYSE: VRX) today. The following letter was disclosed:
Dear Mr. Pearson:
I am delighted to join the Valeant Pharmaceuticals International, Inc. (Valeant) board, and I look forward to making a contribution to the company.
This letter, intended solely for the benefit of Valeant, contains a series of undertakings by myself, my firm and the investment funds that we advise (collectively, Pershing Square or we). The undertakings in the following two paragraphs of this letter will be effective so long as the confidential... More



